Chimerix Inc Revenue Growth Rates (CMRX), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Chimerix Inc   (NASDAQ: CMRX)
 

CMRX's Revenue Growth by Quarter and Year

Chimerix Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

CMRX Revenue (in millions $) FY 2024 FY 2023 FY 2022 FY 2021
4th Quarter December 0.06
3rd Quarter September 0.03
2nd Quarter June 0.13
1st Quarter March 0.00
FY 0.22

CMRXs Annual Revenue
Chimerix Inc 's Revenue in the fiscal year 2024 $ 0.21 millions
Chimerix Inc 's Revenue in the fiscal year 2023 $ 0.32 millions
Chimerix Inc 's Revenue in the fiscal year 2022 $ 33.82 millions
Chimerix Inc 's Revenue in the fiscal year 2021 $ 1.98 millions
Chimerix Inc 's Revenue in the fiscal year 2020 $ 5.37 millions




CMRX Revenue fourth quarter 2024 Y/Y Growth Comment
Chimerix Inc in the fourth quarter 2024 achieved Revenue of $ 0.06 millions compare to recorded in same quarter a year ago.

Looking into fourth quarter 2024 results within Major Pharmaceutical Preparations industry 183 other companies have achieved higher Revenue growth. While Chimerix Inc ' s Revenue no change of 0% ranks overall at the positon no. 3722 in the fourth quarter 2024.


CMRX Revenue ( Y/Y Growth %) 2024
 2023 2022 2021
4th Quarter December - - 1520 % -95.54 %
3rd Quarter September 200 % -99.97 % 29500 % -93.17 %
2nd Quarter June 333.33 % -93.18 % 12.82 % -72.14 %
1st Quarter March - 1300 % -98.61 % 16.13 %
FY   -32.19 % -99.05 % 1600 % -

Financial Statements
Chimerix Inc 's fourth quarter 2024 Revenue $ 0.06 millions CMRX's Income Statement
Chimerix Inc 's fourth quarter 2023 Revenue $ 0.00 millions Quarterly CMRX's Income Statement


CMRX Revenue (Quarter on Quarter Growth %)

 2024
 2023 2022 2021
4th Quarter December 90 % - -97.51 % -54.55 %
3rd Quarter September -76.92 % -66.67 % 7300 % -71.79 %
2nd Quarter June - -89.29 % 2100 % -72.92 %
1st Quarter March - -65.43 % -60 % 28.57 %
FY (Year on Year)   -32.19 % -99.05 % 1600 % -


Back to CMRX Growth rate Comparisons >> Back to CMRX Growth rate Comparisons >>


Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #184
Healthcare Sector #511
Overall #3722

Revenue Y/Y Growth Statistics
High Average Low
5998.75 % 385.47 % -99.04 %
(Mar 31 2023)   (Dec 31 2023)
Revenue fourth quarter 2024 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #184
Healthcare Sector #511
Overall #3722
Revenue Y/Y Growth Statistics
High Average Low
5998.75 % 385.47 % -99.04 %
(Mar 31 2023)   (Dec 31 2023)

Revenue by Quarter for the Fiscal Years 2021, 2022, 2023, 2024

Chimerix Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
7298.86 % 242.06 % -100 %
(Sep 30 2022)  


CMRX's IV. Quarter Q/Q Revenue Comment
Chimerix Inc achieved in the IV. Quarter 2024 below company average Revenue jump of 90% quarter on quarter, to $ 0.06 millions.

Although the IV. Quarter 2024 Revenue Q/Q growth was lower than the regular , this has been yet encouraging story, as the IV. Quarter surge, eclipses the % growth in the IV. Quarter a year ago

Within Major Pharmaceutical Preparations industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Chimerix Inc 's Revenue growth quarter on quarter, overall rank is 215.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #63
Overall #215
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #31
Healthcare Sector #63
Overall #215
Revenue Q/Q Growth Statistics
High Average Low
7298.86 % 242.06 % -100 %
(Sep 30 2022)  


CMRX's IV. Quarter Q/Q Revenue Comment
Chimerix Inc achieved in the IV. Quarter 2024 below company average Revenue jump of 90% quarter on quarter, to $ 0.06 millions.

IV. Quarter 2024 Revenue Q/Q growth were paradoxical, although lower than the regular, yet it demonstrates absolute recovery measured to the % in the IV. Quarter a year ago.

Within Major Pharmaceutical Preparations industry 30 other companies have achieved higher Revenue quarter on quarter growth. While Chimerix Inc 's Revenue growth quarter on quarter, overall rank is 215.


Chimerix Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Dec 31 2024)		 12 Months Ending
(Sep 30 2024)		 12 Months Ending
(Jun 30 2024)		 12 Months Ending
(Mar 31 2024)		 12 Months Ending
(Dec 31 2023)
Cumulative Revenue 12 Months Ending $ 0.00 $ 0.00 $ 0.00 $ 0.00 $ 0.32
Y / Y Revenue Growth (TTM) - - - - -99.04 %
Year on Year Revenue Growth Overall Ranking # 3255 # 2291 # 2 # 3 # 4
Seqeuential Revenue Change (TTM) - - - - -71.43 %
Seq. Revenue Growth (TTM) Overall Ranking # 3629 # 2291 # 1635 # 527 # 1038


Cumulative Revenue growth Comment
Chimerix Inc realized trailing twelve months of $ 0 millions, in the Dec 31 2024, compare to Revenue of $ 0 millions a year ago.

In the Healthcare sector 457 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2291 to 3255.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 180
Healthcare Sector # 458
Overall # 3255

Revenue TTM Y/Y Growth Statistics
High Average Low
5998.75 %
 385.47 %
-99.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 180
Sector # 500
S&P 500 # 3629
Cumulative Revenue growth Comment
Chimerix Inc realized trailing twelve months of $ 0 millions, in the Dec 31 2024, compare to Revenue of $ 0 millions a year ago.

In the Healthcare sector 457 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2291 to 3255.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 180
Healthcare Sector # 458
Overall # 3255

Revenue TTM Y/Y Growth Statistics
High Average Low
5998.75 %
385.47 %
-99.04 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 180
Sector # 500
S&P 500 # 3629




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
CMRX's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue jump for the quarter ending Dec 31 2024 within Healthcare SectorY/Y Change %Revenue for the quarter ending Dec 31 2024
Adapthealth Corp -0.19%$ -0.185 millions
Bioaffinity Technologies Inc -0.26%$ -0.260 millions
Organon and Co -0.38%$ -0.375 millions
Royalty Pharma Plc-0.41%$ -0.407 millions
Carlisle Companies Incorporated-0.41%$ -0.408 millions
Silo Pharma Inc-0.41%$ -0.409 millions
Shl Telemedicine Ltd-0.52%$ -0.519 millions
Cytek Biosciences Inc -0.59%$ -0.586 millions
Kronos Bio Inc -0.70%$ -0.700 millions
Koninklijke Philips Nv-0.81%$ -0.815 millions
Enhabit Inc -0.92%$ -0.921 millions
Charles River Laboratories International inc -1.08%$ -1.078 millions
Elanco Animal Health Incorporated-1.45%$ -1.449 millions
Illumina Inc -1.60%$ -1.604 millions
Perrigo Company Plc-1.62%$ -1.616 millions
Fonar Corporation-1.72%$ -1.717 millions
Quipt Home Medical Corp -1.90%$ -1.905 millions
Bio rad Laboratories Inc -1.91%$ -1.910 millions
Surmodics Inc -2.06%$ -2.062 millions
Avantor Inc -2.10%$ -2.101 millions
Petvivo Holdings Inc -2.11%$ -2.111 millions
Iridex Corp-2.15%$ -2.153 millions
Assertio Holdings inc -2.43%$ -2.431 millions
Apyx Medical Corp-2.58%$ -2.578 millions
Bioxcel Therapeutics Inc -2.66%$ -2.660 millions
Zynex inc -2.66%$ -2.665 millions
Nrc Health-2.88%$ -2.879 millions
Teladoc Health Inc -3.03%$ -3.033 millions
Orchestra Biomed Holdings Inc -3.44%$ -3.435 millions
Xenetic Biosciences Inc -3.45%$ -3.449 millions


About Chimerix Inc Revenue Growth Rates (CMRX), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Chimerix Inc (CIK 1117480).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001117480-25-000004
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Chimerix Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.